{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T15:06:29Z","timestamp":1775142389485,"version":"3.50.1"},"reference-count":136,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T00:00:00Z","timestamp":1666310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012465","name":"Nemours Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012465","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Motor neuron diseases (MNDs) are neuromuscular disorders where the spinal motor neurons\u2013either the cell bodies themselves or their axons\u2013are the primary cells affected. To date, there are 120 different genes that are lost or mutated in pediatric-onset MNDs. Most of these childhood-onset disorders, aside from spinal muscular atrophy (SMA), lack viable therapeutic options. Previous research on MNDs has focused on understanding the pathobiology of a single, specific gene mutation and targeting therapies to that pathobiology. This reductionist approach has yielded therapeutic options for a specific disorder, in this case SMA. Unfortunately, therapies specific for SMA have not been effective against other pediatric-onset MNDs. Pursuing the same approach for the other defined MNDs would require development of at least 120 independent treatments raising feasibility issues. We propose an alternative to this this type of reductionist approach by conceptualizing MNDs in a complex adaptive systems framework that will allow identification of common molecular and cellular pathways which form biological networks that are adversely affected in early-onset MNDs and thus MNDs with similar phenotypes despite diverse genotypes. This systems biology approach highlights the complexity and self-organization of the motor system as well as the ways in which it can be affected by these genetic disorders. Using this integrated approach to understand early-onset MNDs, we would be better poised to expand the therapeutic repertoire for multiple MNDs.<\/jats:p>","DOI":"10.3389\/fneur.2022.1035406","type":"journal-article","created":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T16:01:54Z","timestamp":1679068914000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Biological networks and complexity in early-onset motor neuron diseases"],"prefix":"10.3389","volume":"13","author":[{"given":"Matthew E. R.","family":"Butchbach","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rod C.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/j.nmd.2021.11.004","article-title":"The 2022 version of the gene table of neuromuscular diseases (nuclear genome)","volume":"31","author":"Cohen","year":"2021","journal-title":"Neuromuscul Disord."},{"key":"B2","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1136\/jnnp-2016-313526","article-title":"Differentiating lower motor neuron syndromes","volume":"88","author":"Garg","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B3","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1002\/mds.870120122","article-title":"Reductionism and the study of neurodegenerative disorders","volume":"12","author":"Shulman","year":"1997","journal-title":"Mov Disord."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","article-title":"Nusinersen versus sham control in infantile-onset spinal muscular atrophy","volume":"377","author":"Finkel","year":"2017","journal-title":"N Engl J Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1056\/NEJMoa1710504","article-title":"Nusinersen versus sham control in later-onset spinal muscular atrophy","volume":"378","author":"Mercuri","year":"2018","journal-title":"N Engl J Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1056\/NEJMoa2009965","article-title":"Risdiplam in type 1 spinal muscular atrophy","volume":"384","author":"Baranello","year":"2021","journal-title":"N Engl J Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","article-title":"Single-dose gene-replacement therapy for spinal muscular atrophy","volume":"377","author":"Mendell","year":"2017","journal-title":"N Engl J Med."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41434-022-00349-y.","article-title":"Curing SMA: are we there yet?","author":"Reilly","year":"2022","journal-title":"Gene Ther."},{"key":"B9","doi-asserted-by":"publisher","first-page":"146532","DOI":"10.1016\/j.brainres.2019.146532","article-title":"Overlapping spectrums: the clinicogenetic commonalities between charcot-marie-tooth and other neurodegenerative diseases","volume":"1727","author":"Martin","year":"2020","journal-title":"Brain Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nrg2918","article-title":"Network medicine: a network-based approach to human disease","volume":"12","author":"Barab\u00e1si","year":"2011","journal-title":"Nat Rev Genet."},{"key":"B11","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3389\/fgene.2019.00294","article-title":"Network medicine in the age of biomedical big data","volume":"10","author":"Sonawane","year":"2019","journal-title":"Front Genet."},{"key":"B12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s40142-020-00181-z","article-title":"Network analysis for complex neurodegenerative diseases","volume":"8","author":"Manzoni","year":"2020","journal-title":"Curr Genet Med Rep."},{"key":"B13","doi-asserted-by":"publisher","first-page":"E2371","DOI":"10.1073\/pnas.1301738110","article-title":"Genetic circuitry of Survival motor neuron, the gene underlying spinal muscular atrophy","volume":"110","author":"Sen","year":"2013","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e1005107","DOI":"10.1371\/journal.pgen.1005107","article-title":"Network analyses reveal novel aspects of ALS pathogenesis","volume":"11","author":"Sanheuza","year":"2015","journal-title":"PLoS Genet."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e106818","DOI":"10.1371\/journal.pone.0106818","article-title":"Transcriptome profiling of spinal muscular atrophy motor neurons derived from mouse embryonic stem cells","volume":"9","author":"Maeda","year":"2014","journal-title":"PLoS ONE."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e2007785118","DOI":"10.1073\/pnas.2007785118","article-title":"Impairment of the neurotrophic signaling hub B-Raf contributes to motoneuron degeneration in spinal muscular atrophy","volume":"118","author":"Hensel","year":"2021","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B17","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s40478-015-0231-1","article-title":"Transcriptional profiling of differentially vulnerable motor neurons at pre-symptomatic stage in the Smn2b\/\u2212 mouse model of spinal muscular atrophy","volume":"3","author":"Murray","year":"2015","journal-title":"Acta Neuropathol Commun."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e1006680","DOI":"10.1371\/journal.pgen.1006680","article-title":"Comparison of independent screens on differentially vulnerable motor neurons reveals alpha-synuclein as a common modifier in motor neuron diseases","volume":"13","author":"Kline","year":"2017","journal-title":"PLoS Genet."},{"key":"B19","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s00401-012-1058-5","article-title":"Unravelling the enigma of selective vulnerability in neurodegeneration: motor neurons resistant to degeneration in ALS show distinct gene expression characteristics and decreased susceptibility to excitotoxicity","volume":"125","author":"Brockington","year":"2013","journal-title":"Acta Neuropathol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1093\/brain\/awq167","article-title":"Global gene expression profiling of somatic motor neuron populations with different vulnerability identify molecules and pathways of degeneration and protection","volume":"133","author":"Hedlund","year":"2010","journal-title":"Brain."},{"key":"B21","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.neuron.2013.12.009","article-title":"Neuronal matrix metalloproteinase-9 is a determinant of selective neurodegeneration","volume":"81","author":"Kaplan","year":"2014","journal-title":"Neuron."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1101\/gr.265017.120","article-title":"LCM-seq reveals unique transcriptional adaptation mechanisms of resistant neurons and identified protective pathways in spinal muscular atrophy","volume":"30","author":"Nichterwitz","year":"2020","journal-title":"Genome Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","article-title":"WGCNA: an R package for weighted correlation network analysis","volume":"9","author":"Langfelder","year":"2009","journal-title":"BMC Bioinformatics."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e0157426","DOI":"10.1371\/journal.pone.0157426","article-title":"An integrative transcriptomic analysis for identifying novel target genes corresponding to severity spectrum in spinal muscular atrophy","volume":"11","author":"Yang","year":"2016","journal-title":"PLoS ONE."},{"key":"B25","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1186\/1471-2164-10-405","article-title":"Weighted gene co-expression network analysis of the peripheral blood from amyotrophic lateral sclerosis patients","volume":"10","author":"Saris","year":"2009","journal-title":"BMC Genomics."},{"key":"B26","doi-asserted-by":"publisher","first-page":"874978","DOI":"10.3389\/fimmu.2022.874978","article-title":"Identification of molecular correlations between DHRS4 and progressive neurodegeneration in amyotrophic lateral sclerosis by gene co-expression network analysis","volume":"13","author":"Li","year":"2022","journal-title":"Front Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1086\/421054","article-title":"DNA\/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4)","volume":"74","author":"Chen","year":"2004","journal-title":"Am J Hum Genet."},{"key":"B28","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/ng1303","article-title":"Senataxin, the ortholog of a yeast RNA helicase, is mutant in ataxia-ocular apraxia 2","volume":"36","author":"Moreira","year":"2004","journal-title":"Nat Genet."},{"key":"B29","doi-asserted-by":"publisher","first-page":"4758","DOI":"10.1093\/hmg\/ddu190","article-title":"Mutation of senataxin alters disease-specific transcriptional networks in patients with ataxia with oculomotor apraxia type 2","volume":"23","author":"Fogel","year":"2014","journal-title":"Hum Mol Genet."},{"key":"B30","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s40478-021-01277-5","article-title":"De non pathogenic variant in SETX causes a rapidly progessive neurodegenerative disorder of early childhood-onset with severe axonal polyneuropathy","volume":"9","author":"Hadjinicolaou","year":"2021","journal-title":"Acta Neuropathol Commun."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e0172246","DOI":"10.1371\/journal.pone.0172246","article-title":"The essential and downstream common proteins of amyotrophic lateral sclerosis: a protein-protein interaction network analysis","volume":"12","author":"Mao","year":"2017","journal-title":"PLoS ONE."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e0268159","DOI":"10.1371\/journal.pone.0268159","article-title":"A molecular view of amyotrophic lateral sclerosis through the lens of interaction network modules","volume":"17","author":"Jensen","year":"2022","journal-title":"PLoS ONE."},{"key":"B33","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ibneur.2021.12.002","article-title":"Protein network analysis to prioritize key genes in amyotrophic lateral sclerosis","volume":"12","author":"Kumar","year":"2022","journal-title":"IBRO Neurosci Rep."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1353516","DOI":"10.1155\/2020\/1353516","article-title":"Identification of candidate genes associated with Charcot-Marie-Toot disease by network and pathway analysis","volume":"2020","author":"Zhong","year":"2020","journal-title":"BioMed Res Int."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1038\/s41598-018-37119-z","article-title":"A network biology approach to unraveling inherited axonopathies","volume":"9","author":"Bis-Brewer","year":"2019","journal-title":"Sci Rep."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1093\/brain\/awab226","article-title":"Induced pluripotent stem cell-derived motor neurons of CMT type 2 patients reveal progressive mitochondrial dysfunction","volume":"144","author":"Van Lent","year":"2021","journal-title":"Brain."},{"key":"B37","doi-asserted-by":"publisher","first-page":"11555","DOI":"10.1038\/s41598-018-29990-7","article-title":"Searching for overlap between network modules with specific betweeness (S2B) and its application to cross-disease analysis","volume":"8","author":"Garcia-Vaquero","year":"2018","journal-title":"Sci Rep."},{"key":"B38","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/jnc.13945","article-title":"Linking amyotrophic lateral sclerosis and spinal muscular atrophy through RNA-transcriptome homeostasis: a genomics perspective","volume":"141","author":"Gama-Carvalho","year":"2017","journal-title":"J Neurochem."},{"key":"B39","doi-asserted-by":"publisher","first-page":"8755","DOI":"10.1038\/s41598-018-27136-3","article-title":"Interactome analysis revealed that the U1 snRNP machinery overlaps with the RNAP II machinery and contains multiple ALS\/SMA-causative proteins","volume":"8","author":"Chi","year":"2018","journal-title":"Sci Rep."},{"key":"B40","doi-asserted-by":"publisher","first-page":"11939","DOI":"10.1093\/nar\/gky1093","article-title":"The neurodegenerative diseases ALS and SMA are linked at the molecular level via the ASC-1 complex","volume":"46","author":"Chi","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3390\/brainsci8120212","article-title":"Multi-study proteomic and bioinformatic identification of molecular overlap between amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy (SMA)","volume":"8","author":"\u0160olti\u0107","year":"2018","journal-title":"Brain Sci."},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1177\/26331055221087740","article-title":"Protein network analysis reveals a functional connectivity of dysregulated processes in ALS and SMA","volume":"17","author":"Kubinski","year":"2022","journal-title":"Neurosci Insights."},{"key":"B43","doi-asserted-by":"publisher","first-page":"7896","DOI":"10.3390\/ijms22157896","article-title":"Genomic variability in the Survival Motor Neuron genes (SMN1 and SMN2): implications for spinal muscular atrophy phenotype and therapeutics development","volume":"22","author":"Butchbach","year":"2021","journal-title":"Int J Mol Sci."},{"key":"B44","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1126\/science.1155085","article-title":"Plastin 3 is a protective modifier of autosomal recessive spinal muscular atrophy","volume":"320","author":"Oprea","year":"2008","journal-title":"Science."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1001\/archneurol.2010.239","article-title":"Association of plastin 3 expression with disease severity in spinal muscular atrophy only in postpubertal females","volume":"67","author":"Stratigopoulos","year":"2010","journal-title":"Arch Neurol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/jhg.2013.111","article-title":"Correlation of PLS3 expression with disease severity in children with spinal muscular atrophy","volume":"59","author":"Yanyan","year":"2014","journal-title":"J Hum Genet."},{"key":"B47","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.nmd.2011.03.009","article-title":"Plastin 3 expression in discordant spinal muscular atrophy (SMA) siblings","volume":"21","author":"Bernal","year":"2011","journal-title":"Neuromuscul Disord."},{"key":"B48","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/ped.13052","article-title":"Transcript levels of plastin 3 and neuritin 1 modifer genes in spinal muscular atrophy siblings","volume":"59","author":"Yener","year":"2017","journal-title":"Pediatr Int."},{"key":"B49","doi-asserted-by":"publisher","first-page":"e386","DOI":"10.1212\/NXG.0000000000000386","article-title":"Analysis of FUS, PFN2, TDP-43 and PLS3 as potential disease severity modifiers in spinal muscular atrophy","volume":"6","author":"Wadman","year":"2020","journal-title":"Neurol Genet."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1093\/hmg\/dds540","article-title":"Plastin 3 ameliorates spinal muscular atrophy via delayed axon pruning and improves neuromuscular junction functionality","volume":"22","author":"Ackermann","year":"2013","journal-title":"Hum Mol Genet."},{"key":"B51","doi-asserted-by":"publisher","first-page":"e0132364","DOI":"10.1371\/journal.pone.0132364","article-title":"Plastin 3 expression does not modify spinal muscular atrophy severity in the \u03947 SMA mouse","volume":"10","author":"McGovern","year":"2015","journal-title":"PLoS ONE."},{"key":"B52","doi-asserted-by":"publisher","first-page":"e89970","DOI":"10.1172\/jci.insight.89970","article-title":"Plastin-3 extends survival and reduces severity in mouse models of spinal muscular atrophy","volume":"2","author":"Kaifer","year":"2017","journal-title":"JCI Insight."},{"key":"B53","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.omtm.2018.01.007","article-title":"Plastin 3 promotes motor axonal growth and extends survival in a mouse model of spinal muscular atrophy","volume":"9","author":"Alrafiah","year":"2018","journal-title":"Mol Ther Methods Clin Dev."},{"key":"B54","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.ajhg.2017.01.005","article-title":"Neurocalcin Delta suppression protects against spinal muscular atrophy in humans and acress species by restoring impaired endocytosis","volume":"100","author":"Riessland","year":"2017","journal-title":"Am J Hum Genet."},{"key":"B55","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s12881-019-0935-3","article-title":"Genomic analysis of a spinal muscular atrophy (SMA) discordant family identifies a novel mutation in TLL2, an activator of growth differentiation factor 8 (myostatin): a case report","volume":"20","author":"Jiang","year":"2019","journal-title":"BMC Med Genet."},{"key":"B56","doi-asserted-by":"publisher","first-page":"10337","DOI":"10.1073\/pnas.1104928108","article-title":"Interaction of survival of motor neuron (SMN) with HuD proteins with mRNA cpg15 rescues motor neuron axonal deficits","volume":"108","author":"Akten","year":"2011","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B57","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/hmg\/ddu440","article-title":"Junctophilin-1 is a modifier gene of GDAP1-related Charcot-Marie-Tooth disease","volume":"24","author":"Pla-Mart\u00edn","year":"2015","journal-title":"Hum Mol Genet."},{"key":"B58","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/nature15510","article-title":"CMT2D neuropathy is linked to the neomorphic binding activity of glycyl-tRNA synthetase","volume":"526","author":"He","year":"2015","journal-title":"Nature."},{"key":"B59","doi-asserted-by":"publisher","first-page":"3178","DOI":"10.1016\/j.celrep.2017.03.009","article-title":"Severity of demyelinating and axonal neuropathy mouse models is modified by genes affecting structure and function of peripheral nodes","volume":"18","author":"Morelli","year":"2017","journal-title":"Cell Rep."},{"key":"B60","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/s41434-021-00303-4","article-title":"Upper motor neurons are a target for gene therapy and UCHL1 is necessary and sufficient to improve cellular integrity of diseased upper motor neurons","volume":"29","author":"Gen\u00e7","year":"2022","journal-title":"Gene Ther."},{"key":"B61","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.neuron.2010.12.032","article-title":"Early functional impairment of sensory-motor connectivity in a mouse model of spinal muscular atrophy","volume":"69","author":"Mentis","year":"2011","journal-title":"Neuron."},{"key":"B62","doi-asserted-by":"publisher","first-page":"e0267990","DOI":"10.1371\/journal.pone.0267990","article-title":"Neuromuscular denervation and deafferentation but not motor neuron death are disease features in the Smn2B\/\u2212 mouse model of SMA","volume":"17","author":"Carlini","year":"2022","journal-title":"PLoS ONE."},{"key":"B63","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1093\/brain\/awy237","article-title":"UBA1\/GARS-dependent pathways drive sensory-motor connectivity defects in spinal muscular atrophy","volume":"141","author":"Shorrock","year":"2018","journal-title":"Brain."},{"key":"B64","doi-asserted-by":"publisher","first-page":"104870","DOI":"10.1016\/j.nbd.2020.104870","article-title":"Glial cells involvement in spinal muscular atrophy: could SMA be a neuroinflammatory disease?","volume":"140","author":"Abati","year":"2020","journal-title":"Neurobiol Dis."},{"key":"B65","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/j.1440-1789.2008.00910.x","article-title":"An autopsy case of spinal muscular atrophy type III (Kugelberg-Welander disease)","volume":"29","author":"Kuru","year":"2009","journal-title":"Neuropathology."},{"key":"B66","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1007\/s004150170203","article-title":"Hereditary pure lower motor neuron disease with adult onset and rapid progression","volume":"248","author":"Van den Berg-Vos","year":"2001","journal-title":"J Neurol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1007\/s00415-008-0847-1","article-title":"Cerebral involvement in axonal Charcot-Marie-Tooth neuropathy caused by mitofusin2 mutations","volume":"255","author":"Brockmann","year":"2008","journal-title":"J Neurol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1097\/NEN.0000000000000074","article-title":"Mechanisms involved in spinal cord central synapse loss in a mouse model of spinal muscular atrophy","volume":"73","author":"Tarabal","year":"2014","journal-title":"J Neuropathol Exp Neurol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"4094","DOI":"10.1093\/hmg\/ddv148","article-title":"Astrocytes influence the severity of spinal muscular atrophy","volume":"24","author":"Rindt","year":"2015","journal-title":"Hum Mol Genet."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1002\/glia.22522","article-title":"Spinal muscular atrophy astrocytes exhibit abnormal calcium regulation and reduced growth factor production","volume":"61","author":"McGivern","year":"2013","journal-title":"Glia."},{"key":"B71","doi-asserted-by":"publisher","first-page":"3701","DOI":"10.1038\/s41598-019-39788-w","article-title":"Notch signaling mediates astrocyte abnormality in spinal muscular atrophy model systems","volume":"9","author":"Ohuchi","year":"2019","journal-title":"Sci Rep."},{"key":"B72","doi-asserted-by":"publisher","first-page":"5309","DOI":"10.1523\/JNEUROSCI.3472-16.2017","article-title":"Decreased motor neuron support by SMA astrocytes due to diminished MCP1 secretion","volume":"37","author":"Martin","year":"2017","journal-title":"J Neurosci."},{"key":"B73","doi-asserted-by":"publisher","first-page":"3409","DOI":"10.1093\/hmg\/ddx230","article-title":"Astrocyte-produced miR-146a as a mediator of motor neuron loss in spinal muscular atrophy","volume":"26","author":"Sison","year":"2017","journal-title":"Hum Mol Genet."},{"key":"B74","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1523\/JNEUROSCI.3534-15.2016","article-title":"Defects in motoneuron-astrocyte interactions in spinal muscular atrophy","volume":"36","author":"Zhou","year":"2016","journal-title":"J Neurosci."},{"key":"B75","doi-asserted-by":"publisher","first-page":"e15457","DOI":"10.1371\/journal.pone.0015457","article-title":"Synaptic defects in the spinal and neuromuscular circuitry in a mouse model of spinal muscular atrophy","volume":"5","author":"Ling","year":"2010","journal-title":"PLoS One."},{"key":"B76","doi-asserted-by":"publisher","first-page":"113004","DOI":"10.1016\/j.expneurol.2019.113004","article-title":"Neuroinflammation in the pathogenesis of axonal Charcot-Marie-Tooth disease caused by lack of GDAP1","volume":"320","author":"Fernandez-Lizarbe","year":"2019","journal-title":"Exp Neurol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1002\/glia.24177","article-title":"Survival motor neuron protein deficiency alters microglia reactivity","volume":"70","author":"Khayrullina","year":"2022","journal-title":"Glia."},{"key":"B78","doi-asserted-by":"publisher","first-page":"3087","DOI":"10.1016\/j.celrep.2019.11.013","article-title":"The classical complement pathway mediates microglia-dependent remodeling of spinal motor circuits during development and in SMA","volume":"29","author":"Vukojicic","year":"2019","journal-title":"Cell Rep."},{"key":"B79","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1093\/jnen\/nly033","article-title":"Glial activation and central synapse loss, but not motoneuron degeneration, are prevented by the sigma-1 receptor agonist PRE-084 in the Smn2B\/\u2212 mouse model of spinal muscular atrophy","volume":"77","author":"Cerver\u00f3","year":"2018","journal-title":"J Neuropathol Exp Neurol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1002\/wsbm.1181","article-title":"Complexity and the reduction-holism debate in systems biology","volume":"4","author":"Mazzocchi","year":"2012","journal-title":"Wiley Interdiscip Rev Syst Biol Med."},{"key":"B81","doi-asserted-by":"publisher","first-page":"6105872","DOI":"10.1155\/2020\/6105872","article-title":"An introduction to complex systems science and its applications","volume":"2020","author":"Siegenfeld","year":"2020","journal-title":"Complexity."},{"key":"B82","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1177\/1073858421994784","article-title":"A complex systems perspective on neuroimaging studies of behavior and its disorders","volume":"28","author":"Turkheimer","year":"2022","journal-title":"Neuroscientist."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1111\/epi.14503","article-title":"WONOEP APPRAISAL: the many facets of epilepsy networks","volume":"59","author":"Scott","year":"2018","journal-title":"Epilepsia."},{"key":"B84","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.seizure.2021.02.001","article-title":"Brains, complex systems and therapeutic opportunities in epilepsy","volume":"90","author":"Scott","year":"2021","journal-title":"Seizure."},{"key":"B85","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/s41593-020-00795-0","article-title":"Single-cell transcriptomic analysis of the adult mouse spinal cord reveals molecular diversity of autonomic and skeletal motor neurons","volume":"24","author":"Blum","year":"2021","journal-title":"Nat Neurosci."},{"key":"B86","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.conb.2020.12.002","article-title":"In vitro models of spinal motor circuit's development in mammals: achievements and challenges","volume":"66","author":"Nedelec","year":"2021","journal-title":"Curr Opin Neurobiol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3389\/fncel.2014.00293","article-title":"Motor neurons and the generation of spinal motor neuron diversity","volume":"8","author":"Stifani","year":"2014","journal-title":"Front Cell Neurosci."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1152\/jn.00242.2021","article-title":"A model for self-organization of sensorimotor function: the spinal monosynaptic loop","volume":"127","author":"Enander","year":"2022","journal-title":"J Neurophysiol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1152\/jn.00054.2022","article-title":"A model for self-organization of sensorimotor function: spinal interneuronal integration","volume":"127","author":"Enander","year":"2022","journal-title":"J Neurophysiol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1113\/EP089711","article-title":"Physiological complexity: influence of ageing, disease and neuromuscular fatigue on muscle force and torque fluctuations","volume":"106","author":"Pethick","year":"2021","journal-title":"Exp Physiol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"12207","DOI":"10.1523\/JNEUROSCI.0240-15.2015","article-title":"Motor neuron pools of synergistic thigh muscles share most of their synaptic input","volume":"35","author":"Laine","year":"2015","journal-title":"J Neurosci."},{"key":"B92","doi-asserted-by":"publisher","first-page":"eabc3916","DOI":"10.1126\/sciadv.abc3916","article-title":"Spinal motoneurons of the human newborn are highly synchronized during leg movements","volume":"6","author":"Del Vecchio","year":"2020","journal-title":"Sci Adv."},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1113\/JP283040","article-title":"Correlation networks of spinal motor neurons that innervate lower limb muscles during a multi-joint isometric task","author":"Hug","year":"2022","journal-title":"J Physiol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0197-4580(01)00266-4","article-title":"What is physiologic complexity and how does it change with aging and disease?","volume":"23","author":"Goldberger","year":"2002","journal-title":"Neurobiol Aging."},{"key":"B95","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0197-4580(01)00247-0","article-title":"Changing complexity in human behavior and physiology through aging and disease","volume":"23","author":"Vaillancourt","year":"2002","journal-title":"Neurobiol Aging."},{"key":"B96","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s13760-014-0335-6","article-title":"Fasciculations in human hereditary disease","volume":"115","author":"Finsterer","year":"2015","journal-title":"Acta Neurol Belg."},{"key":"B97","doi-asserted-by":"publisher","first-page":"fcaa189","DOI":"10.1093\/braincomms\/fcaa189","article-title":"Accurate interpretation of fasciculation frequency in amyotrophic lateral sclerosis hinges on both muscle type and stage of disease","volume":"2","author":"Bashford","year":"2020","journal-title":"Brain Commun."},{"key":"B98","doi-asserted-by":"publisher","first-page":"fcaa018","DOI":"10.1093\/braincomms\/fcaa018","article-title":"The rise and fall of fasciculations in amyotrophic lateral sclerosis","volume":"2","author":"Bashford","year":"2020","journal-title":"Brain Commun."},{"key":"B99","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1136\/jnnp-2017-315574","article-title":"Fasciculation in amyotrophic lateral sclerosis: origin and pathophysiological relevance","volume":"88","author":"de Carvalho","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B100","doi-asserted-by":"publisher","first-page":"fcaa188","DOI":"10.1093\/braincomms\/fcaa188","article-title":"Fasciculation frequency is a questionable biomarker for motor unit loss in amyotrophic lateral sclerosis","volume":"2","author":"Finsterer","year":"2020","journal-title":"Brain Commun."},{"key":"B101","doi-asserted-by":"publisher","first-page":"5208","DOI":"10.4081\/ni.2014.5208","article-title":"Another perspective on fasciculations: when is it not caused by the classic form of amyotrophic lateral sclerosis or progressive spinal atrophy?","volume":"6","author":"Leite","year":"2014","journal-title":"Neurol Int."},{"key":"B102","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1136\/adc.48.5.386","article-title":"Spinal muscular atrophy in childhood: two clues to clinical diagnosis","volume":"48","author":"Moosa","year":"1973","journal-title":"Arch Dis Child."},{"key":"B103","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.pediatrneurol.2012.12.027","article-title":"Type III spinal muscular atrophy mimicking muscular dystrophies","volume":"48","author":"Alsaman","year":"2013","journal-title":"Pediatr Neurol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.nmd.2022.07.395","article-title":"Accuracy of muscle fasciculations for the diagnosis of later-onset spinal muscle atrophy","volume":"32","author":"dos Santos","year":"2022","journal-title":"Neuromuscul Disord."},{"key":"B105","doi-asserted-by":"publisher","first-page":"3242","DOI":"10.1093\/brain\/awp258","article-title":"Clinical features of spinal and bulbar muscular atrophy","volume":"132","author":"Rhodes","year":"2009","journal-title":"Brain."},{"key":"B106","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3389\/fneur.2020.00045","article-title":"The need for SMN-independent treatments of spinal muscular atrophy (SMA) to complement SMN-enhancing drugs","volume":"11","author":"Hensel","year":"2020","journal-title":"Front Neurol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"730257","DOI":"10.3389\/fphar.2021.730257","article-title":"Single-target versus multi-target drugs versus combinations of drugs with multiple targets: preclinical and clinical evidence for the treatment or prevention of epilepsy","volume":"12","author":"L\u00f6scher","year":"2021","journal-title":"Front Pharmacol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.expneurol.2016.02.009","article-title":"Protective effects of butyrate-based compounds on a mouse model for spinal muscular atrophy","volume":"279","author":"Butchbach","year":"2016","journal-title":"Exp Neurol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/sj.ejhg.5201102","article-title":"Phenylbutyrate increases SMN expression in vitro: relevance for treatment of spinal muscular atrophy","volume":"12","author":"Andreassi","year":"2004","journal-title":"Eur J Hum Genet."},{"key":"B110","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/sj.ejhg.5201320","article-title":"Phenylbutyrate increases SMN gene expression in spinal muscular atrophy patients","volume":"13","author":"Brahe","year":"2005","journal-title":"Eur J Hum Genet."},{"key":"B111","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1038\/ejhg.2011.89","article-title":"Treatment of spinal muscular atrophy cells with drugs that upregulate SMN expression reveals inter- and intra-patient variability","volume":"19","author":"Also-Rallo","year":"2011","journal-title":"Eur J Hum Genet."},{"key":"B112","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.nmd.2003.11.006","article-title":"Pilot trial of phenylbutyrate in spinal muscular atrophy","volume":"14","author":"Mercuri","year":"2004","journal-title":"Neuromuscul Disord."},{"key":"B113","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1212\/01.wnl.0000249142.82285.d6","article-title":"Randomized, double-blind, placebo-controlled trial of phenylbutyrate in spinal muscular atrophy","volume":"68","author":"Mercuri","year":"2007","journal-title":"Neurology."},{"key":"B114","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1111\/j.1471-4159.2005.03077.x","article-title":"Sodium phenylbutyrate prolongs survival and regulates expression of anti-apoptotic genes in transgenic amyotrophic lateral sclerosis mice","volume":"93","author":"Ryu","year":"2005","journal-title":"J Neurochem."},{"key":"B115","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.nbd.2005.09.013","article-title":"Additive neuroprotective effects of a histone deacetylase inhibitor and a catalytic antioxidant in a transgenic mouse model of amyotrophic lateral sclerosis","volume":"22","author":"Petri","year":"2006","journal-title":"Neurobiol Dis."},{"key":"B116","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1080\/17482960802226148","article-title":"Combined riluzole and sodium phenylbutyrate therapy in transgenic amyotrophic lateral sclerosis mice","volume":"10","author":"Del Signore","year":"2009","journal-title":"Amyotroph Lateral Scler."},{"key":"B117","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1080\/17482960802320487","article-title":"Phase 2 study of sodium phenylbutyrate in ALS","volume":"10","author":"Cudkowicz","year":"2009","journal-title":"Amyotroph Lateral Scler."},{"key":"B118","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1056\/NEJMoa1916945","article-title":"Trial of sodium phenylbutyrate-taurursodiol for amyotrophic lateral sclerosis","volume":"383","author":"Paganoni","year":"2020","journal-title":"N Engl J Med."},{"key":"B119","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/s41467-017-00911-y","article-title":"HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUS-ALS patients","volume":"8","author":"Guo","year":"2017","journal-title":"Nat Commun."},{"key":"B120","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1016\/j.stemcr.2021.03.029","article-title":"Human motor units in microfluidic devises are impaired by FUS mutations and improved by HDAC6 inhibition","volume":"16","author":"Stoklund Dittlau","year":"2021","journal-title":"Stem Cell Rep."},{"key":"B121","doi-asserted-by":"publisher","first-page":"e106177","DOI":"10.15252\/embj.2020106177","article-title":"HDAC6 inhibition restores TDP-43 pathology and axonal transport defects in human motor neurons with TARDBP mutations","volume":"40","author":"Fazal","year":"2021","journal-title":"EMBO J."},{"key":"B122","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/nm.2396","article-title":"HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1-induced Charcot-Marie-Tooth disease","volume":"17","author":"d'Ydewalle","year":"2011","journal-title":"Nat Med."},{"key":"B123","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1038\/s41467-018-03461-z","article-title":"Aberrant GlyRS-HDAC6 interaction linked to axonal transport deficits in Charcot-Marie-Tooth neuropathy","volume":"9","author":"Mo","year":"2018","journal-title":"Nat Commun."},{"key":"B124","doi-asserted-by":"publisher","first-page":"2101308","DOI":"10.1002\/adbi.202101308","article-title":"HDAC6 inhibition corrects electrophysiological and axonal transport deficits in a human stem cell-based model of Charcot-Marie-Tooth disease (type 2D)","volume":"6","author":"Smith","year":"2022","journal-title":"Adv Biol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"231","DOI":"10.14348\/molcells.2022.5005","article-title":"Therapeutic potential of CKD-504, a novel selective histone deacetylase 6 inhibitor, in a zebrafish model of neuromuscular junction disorders","volume":"45","author":"Jeong","year":"2022","journal-title":"Mol Cells."},{"key":"B126","doi-asserted-by":"publisher","first-page":"113281","DOI":"10.1016\/j.expneurol.2020.113281","article-title":"HDAC6 inhibition promotes \u03b1-tubulin acetylation and ameliorates CMT2A peripheral neuropathy in mice","volume":"328","author":"Picci","year":"2020","journal-title":"Exp Neurol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s40478-019-0750-2","article-title":"Restoration of histone acetylation ameliorates disease and metabolic abnormalities in a FUS mouse model","volume":"7","author":"Rossaert","year":"2019","journal-title":"Acta Neuropathol Commun."},{"key":"B128","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1021\/acschemneuro.5b00286","article-title":"Bicyclic-capped histone deacetylase 6 inhibitors with improved activity in a model of axonal Charcot-Marie-Tooth disease","volume":"7","author":"Shen","year":"2016","journal-title":"ACS Chem Neurosci."},{"key":"B129","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s13311-016-0501-z","article-title":"Development of improved HDAC6 inhibitors as pharmacological therapy for axonal Charcot-Marie-Tooth disease","volume":"14","author":"Benoy","year":"2017","journal-title":"Neurotherapeutics."},{"key":"B130","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1021\/acschemneuro.9b00338","article-title":"Novel HDAC6 inhibitors increase tubulin acetylation and rescue axonal transport of mitochondria in a model of Charcot-Marie-Tooth type 2F","volume":"11","author":"Adalbert","year":"2020","journal-title":"ACS Chem Neurosci."},{"key":"B131","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/cells10010012","article-title":"HDAC6 in diseases of cognition and of neurons","volume":"10","author":"LoPresti","year":"2021","journal-title":"Cells."},{"key":"B132","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1093\/hmg\/ddt028","article-title":"Hdac6 deletion delays disease progression in the SOD1G93A mouse model of ALS","volume":"22","author":"Taes","year":"2013","journal-title":"Hum Mol Genet."},{"key":"B133","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.nmd.2015.05.008","article-title":"The effect of the DcpS inhibitor D156844 on the protective action of follistatin in mice with spinal muscular atrophy","volume":"25","author":"Harris","year":"2015","journal-title":"Neuromuscul Disord."},{"key":"B134","doi-asserted-by":"publisher","first-page":"105488","DOI":"10.1016\/j.nbd.2021.105488","article-title":"Dual SMN inducing therapies can rescue survival and motor unit function in symptomatic \u03947 SMA mice","volume":"159","author":"Kray","year":"2021","journal-title":"Neurobiol Dis."},{"key":"B135","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1016\/j.cell.2022.04.031","article-title":"Counteracting chromatin effects of a splicing-correcting antisense oligonucleotide improves its therapeutic efficacy in spinal muscular atrophy","volume":"185","author":"Marasco","year":"2022","journal-title":"Cell."},{"key":"B136","doi-asserted-by":"publisher","first-page":"2984","DOI":"10.1093\/hmg\/ddac068","article-title":"A combinatorial approach increases SMN level in SMA model mice","volume":"31","author":"Dumas","year":"2022","journal-title":"Hum Mol Genet."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.1035406\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T16:01:59Z","timestamp":1679068919000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.1035406\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,21]]},"references-count":136,"alternative-id":["10.3389\/fneur.2022.1035406"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2022.1035406","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,21]]},"article-number":"1035406"}}